RG
Richard S Geary (EVP, Chief Development Officer) filed 6 Form 4 reports in the past 24 months (0 purchases, 6 sales), most often in Ionis Pharmaceuticals, Inc. (IONS). The largest single filing was $6.7M of IONS (89,249 sh across 3 lots, as filed), executed Oct 31 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
6
0 buys · 6 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$14.1M
shares × price, as filed
Last traded
Nov 6 2025
Filed Nov 7 2025
Median ADV $142.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $14.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
6 filings
Sector per market data · by filing · past 24 months
Most traded names
IONS
Ionis Pharmaceuticals, Inc.
IONS · 0 buys · 6 sells
6 filings
Recent filings
IONSSALE
Ionis Pharmaceuticals, Inc.
View filing →
$2.5M33,038 sh across 2 lots
Exec Nov 6 2025
Filed Nov 7 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. View filing → $6.7M
89,249 sh across 3 lots
Exec Oct 31 2025
Filed Nov 3 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. View filing → $3.8M
57,900 sh × $65.24
Exec Sep 30 2025
Filed Oct 1 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. View filing → $504K
10,000 sh × $50.37
Exec Sep 2 2025
Filed Sep 4 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. View filing → $429K
10,000 sh × $42.86
Exec Aug 5 2025
Filed Aug 6 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. View filing → $232K
7,072 sh × $32.86
Exec Jan 16 2025
Filed Jan 17 2025 · 5:30 PM ET